Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients

Abstract

GPS or mGPS is an accurate prognostic predictor in patients with CRC. Patients with elevated pretreatment GPS or mGPS have a poor prognosis. Subgroup analyses confirmed the overall outcomes. Pretreatment GPS is a useful biomarker in the management of CRC.